Pricing Log in Create free account
Friday 6 November 2026 Export BMRN’s income statement to Excel — free account

BioMarin Pharmaceutical Inc.

BMRN Healthcare Biotechnology

BioMarin Pharmaceutical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 12.9% from fiscal 2024.

Revenue
+32.0%
EPS
−296.6%
Free cash flow
−52.3%
Total debt
+599.5%

Quarter to September 2026, against a year earlier

55.69 0.43 −0.77%
Market cap
$10.9B
P/E
0.0×
Fwd P/E
32.7×
Dividend yield
—
F-score
5/9
Altman Z
5.67
Beneish M
−2.49
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

BioMarin Pharmaceutical Inc. (BMRN) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, BioMarin Pharmaceutical Inc. (BMRN) trades at a EV/Sales of 3.9×. Over the past ten years it has ranged from 2.9× (May 2026) to 27.8× (July 2015); the current reading is higher than 11% of that period. That is below the Biotechnology industry median of 9.0× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 3.4× (22.18%)
FY2024 4.4× (42.77%)
FY2023 7.6× (13.41%)
FY2022 8.8× 0.08%
FY2021 8.8× 3.01%
FY2020 8.5× (4.53%)
FY2019 8.9× (12.29%)
FY2018 10.2× (14.49%)
FY2017 11.9× (5.87%)
FY2016 12.7× (33.06%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 4.1× (2.44%)
Jun 2026 4.2× 29.40%
Mar 2026 3.3× (3.86%)
Dec 2025 3.4× 4.83%
43 more quarters

Against its own ten years

Low 2.9× High 27.8×
Ten-year median 8.7×
Current reading's percentile 12

EV/Sales against peers

Company EV/Sales
PCVX Vaxcyte, Inc. compare n/m
BMRN BioMarin Pharmaceutical Inc. 3.9×
CAI Caris Life Sciences,�Inc. compare 6.8×
TECH Bio-Techne Corp compare 9.3×
TGTX TG Therapeutics, Inc. compare 10.5×
TWST Twist Bioscience Corporation compare 17.3×
IBRX ImmunityBio, Inc. compare 56.5×
KYMR Kymera Therapeutics, Inc. compare 111×
SMMT Summit Therapeutics PLC compare 15,046×
Biotechnology industry median 9.0×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on BMRN